Pfizer | Michigan Radio
WUOMFM

Pfizer

courtesy of Spectrum Health

Governor Gretchen Whitmer wants Michigan to buy up to 100,000 of doses of Pfizer’s coronavirus vaccine on its own.

The federal government already arranged to buy 200 million doses of the vaccine from Pfizer, and it’s been coordinating distribution to the states.

But Governor Whitmer, along with governors from eight other states, says that process is taking too long.

man in a mask gets a vaccine from health care worker in a mask
Adobe Stock

This weekend, a convoy of trucks rolled out of the Pfizer manufacturing plant in Portage, carrying the first doses of the freshly-FDA-approved COVID-19 vaccine. As people watched this historic moment, hopes soared  that this could be the beginning of the end of this deadly pandemic. Dr. Joneigh Khaldun, Michigan’s chief medical executive, was one of those people.

Steve Carmody / Michigan Radio

The drug company Pfizer is producing an experimental version of a COVID-19 vaccine at its facility in Kalamazoo.

The company says that test version will be used in clinical trials that are already underway.

It’s one of several potential vaccines that have been approved for control group testing.

Steve Carmody / Michigan Radio

A proposed $100 billion merger of two giant drug companies may have an impact on thousands of people in Michigan.

Pfizer confirmed it’s talking with Britain's AstraZeneca about merging or combining their operations.

Pfizer employs about 2,300 people in Michigan, most of them in Kalamazoo County.

About 750 Pfizer employees in Kalamazoo are going to have a new boss.

Pfizer announced today it's spinning its “animal health” division off into its own company.

The new company’s name will be Zoetis. An odd, though appropriate name for the company. The Z-O in Zoetis is supposed to stand for ZOO, or zoetic, which means "pertaining to life".

Pfizer’s animal health division is a major employer in Kalamazoo. Damien Conover expects that will stay the same under the new company. Conover is an analyst with Morningstar Financial.

“There’s probably going to be some consolidation with the new business,” says Conover,  “but for the most part I’m not anticipating a big shakeup of the business.”

Conover expects Zoetis will be worth more than eleven billion dollars. That would make it the largest stand-alone company focused on animal pharmaceuticals in the world.

NEW YORK (AP) Pfizer says it may sell its animal health and nutrition business in the next two years so it can focus on expanding its low-cost pharmaceuticals unit.

Pfizer says it will also consider transactions including spinoffs and may pursue different strategies for each business. It said any transactions could take one to two years to complete.

The businesses brought Pfizer Inc. $5.5 billion in revenue in 2010, about 8 percent of its total. The Animal Health unit makes vaccines, medicines, diagnostics and other items to prevent and treat diseases in livestock and pets, and the nutrition unit makes infant and pediatric products.

The New York drugmaker say it will focus on its established products business, which makes drugs that are off-patent or are losing patent protection.

The University of Michigan has announced that it's planning a new health care policy institute in the
complex that once belonged to drugmaker Pfizer Inc.

The university said Thursday the Institute for Health Care Policy and Innovation aims to inform and influence public policy and enhance efforts to improve health care services.

More than 500 researchers eventually could be part of the new institute at the North Campus Research Complex, Pfizer's former research and development center the Ann Arbor school bought in 2009
for $108 million.

The university says it will launch a national search for an institute director. It expects a $13.7 million renovation project to be completed next spring.

Photo courtesy of the University of Michigan

A new type of incubator is open for business at the University of Michigan. It’s called a “venture accelerator,” and it’s located in the  sprawling research complex Pfizer built before it left Michigan a few years ago.